Prelude Therapeutics
PRLD
PRLD
60 hedge funds and large institutions have $1.41B invested in Prelude Therapeutics in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 8 reducing their positions, and 8 closing their positions.
Holders
60
Holders Change
+9
Holders Change %
+17.65%
% of All Funds
1.06%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
17
Increased
30
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$271M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$37.8M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$37.6M |
| 4 |
4
Federated Hermes
Pittsburgh,
Pennsylvania
|
$14.6M |
| 5 |
5
UBS AM
Chicago,
Illinois
|
$27.9M |
